PSYK ETF (PSYK) Research
The fund's manager utilizes a passive investment strategy, aiming to closely mirror the returns of its target index. This benchmark is systematically constructed based on specific criteria, focusing on companies engaged in the legal development and application of psychedelic treatments for various medical conditions, adhering to the regulatory frameworks of the respective countries. Generally, the fund will acquire all of the index's constituent securities, maintaining portfolio weightings that approximate their representation within the index. It is important to note that this fund is non-diversified.
Market snapshot
- Symbol
- PSYK
- Price
- $16.48
- Day change
- +0.30%
- Market cap
- $1.9M
- 52-week range
- 16.1-19.15
- Sector
- Financial Services
- Industry
- Asset Management
Peer companies
- Emles Made in America ETF (AMER)
- Reality Shares Nasdaq NexGen Economy China ETF (BCNA)
- SoFi Smart Energy ETF (ENRG)
- Foundations Dynamic Core ETF (FDCE)
- Franklin FTSE South Africa ETF (FLZA)
- KraneShares Emerging Markets Healthcare Index ETF (KMED)
- AdvisorShares Q Portfolio Blended Allocation ETF (QPT)
- ProShares Short Basic Materials (SBM)
Open PSYK ETF (PSYK) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.